miR-30a suppresses osteosarcoma proliferation and metastasis by downregulating MEF2D expression

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNAs (miRNAs) are key regulators in cancer development.
• miRNA-30a (miR-30a) is involved in various cancers, but its role in osteosarcoma is unknown.

Purpose of the Study:

• To investigate the role of miR-30a in osteosarcoma.
• To identify miR-30a targets and elucidate its mechanism of action in osteosarcoma.

Main Methods:

• Quantitative real-time polymerase chain reaction (qRT-PCR) to measure miR-30a levels.
• In vitro assays to assess cell growth, migration, and invasion.
• Bioinformatics, luciferase reporter assay, RT-PCR, and Western blotting to identify and validate miR-30a targets.

Main Results:

• miR-30a was significantly downregulated in osteosarcoma tissues and cell lines.
• miR-30a inhibited osteosarcoma cell proliferation, migration, and invasion.
• MEF2D was identified as a direct target of miR-30a, and miR-30a reduced MEF2D expression.
• MEF2D overexpression partially reversed the effects of miR-30a.

Conclusions:

• miR-30a acts as a tumor suppressor in osteosarcoma by targeting MEF2D.
• miR-30a represents a potential prognostic biomarker and therapeutic target for osteosarcoma.